Home » Industry Insights » Top Biotech News (16 June 2026)

Top Biotech News (16 June 2026)

Scientists discover a surprising cancer link to Alzheimer’s disease

Summary:

Scientists at Boston Children’s Hospital found cancer-like mutations hiding in immune cells that may help drive Alzheimer’s disease, revealing a surprising new target for diagnosis and treatment.

Science sleuths uncover more than 100 suspicious images in Thermo Fisher antibody catalogue

Summary:

Catalogue entries for more than 100 antibodies sold by the research services and supply company Thermo Fisher Scientific contain images that have apparently been manipulated, according to a pair of researchers who specialize in scientific-integrity issues.

Sanofi stops immune drug trial in latest research setback

Summary:

The failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.

Caribou boosts case that off-the-shelf CAR-T matches autologous drugs ahead of phase 3

Summary:

Caribou Biosciences has linked its CAR-T cell therapy candidate to 17.1-month median progression-free survival (PFS), adding to evidence that the off-the-shelf treatment can match the efficacy of autologous products in lymphoma patients.

4 things to know about the new sunscreen ingredient the FDA approved

Summary:

For the first time in nearly three decades, the Food and Drug Administration approved a new chemical UV filter for use in sunscreens sold in the U.S. And that has many dermatologists cheering.

Subscribe
to the latest updates in the newsletter

Related Solutions

  • Disease Modeling
  • Oncology
  • Organoid
  • Cosmetics
  • OECD TG
  • Zebrafish
  • Bioinfomatics
  • Live&3D Imaging
  • Molecular biology
  • Spatial Biology
Technical Service

Next Articles

Thank you for your submission.

Our team has received your request and will get back to you shortly with tailored workflows and relevant case studies for your ADC efficacy and toxicity evaluation needs.
If you do not receive our confirmation email, kindly check your spam or junk folder.

Thank you for your insterest

You can now download the file.

Connect with Us